Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcin
Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma.
Primary liver cancer is the fifth most common malignancy in the world and is a leading cause of cancer-related mortality. Available treatment for hepatocellular carcinoma (HCC), the commonest primary liver cancer, is rarely curative and there is a need to […]